ISPOR 2026 in Philadelphia is a wrap! Three days – big conversations. Our team had a great conference and many in-depth discussions on the evolving role of HEOR, market access, real-world evidence and patient-centered research and how to better support healthcare decision-making. Let’s continue the conversation – reach out to connect with our experts on the questions that will help you navigate change and move forward with confidence. https://bit.ly/3Q3Df1c
About us
IQVIA (NYSE:IQV) is a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries. IQVIA’s portfolio of solutions are powered by IQVIA Connected Intelligence™ to deliver actionable insights and services built on high-quality health data, Healthcare-grade AI™, advanced analytics, the latest technologies and extensive domain expertise. With approximately 88,000 employees in over 100 countries, including experts in healthcare, life sciences, data science, technology and operational excellence, IQVIA is dedicated to accelerating the development and commercialization of innovative medical treatments to help improve patient outcomes and population health worldwide. IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific progress, in an effort to advance healthcare. To learn more, visit www.iqvia.com.
- Website
-
https://www.iqvia.com/
External link for IQVIA
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Durham, North Carolina
- Type
- Public Company
- Specialties
- Technology, Consulting, and Clinical Development
Locations
-
Primary
Get directions
2400 Ellis Rd
Durham, North Carolina 27703, US
Employees at IQVIA
Updates
-
Your IQVIA journey doesn't end when you leave. Our Alumni Network provides former IQVIA employees with a place to reconnect, attend exclusive events and stay informed about career opportunities. Register here: https://bit.ly/42SpLs1 #WeAreIQVIA
-
-
Introducing a new way work gets done in life sciences. IQVIA.ai brings data, AI and execution together in a single, unified platform. Explore IQVIA.ai: https://lnkd.in/dUf7jn_z
-
We are growing our technology and analytics teams at IQVIA! Join us in shaping the future of healthcare: https://bit.ly/4un7OxJ #WeAreIQVIA
-
-
Oncology Evidence Network (OEN) is expanding! By combining access to a growing network of European cancer hospitals and registries with IQVIA’s deep clinical expertise, OEN enables the generation of high-quality, complex real world oncology evidence at scale. Building on strong partnerships across multiple countries, Switzerland now joins the network as new key market—further strengthening OEN’s global reach and impact. Learn more: https://bit.ly/4wJimJ3
-
Faster decisions require smarter validation. In this IQVIA white paper, discover how synthetic advisory boards (S‑ABs) use AI-powered digital twins—combined with human oversight—to explore scenarios ahead of live advisory boards. Read now: https://lnkd.in/eef3nSFe
Biopharma decisions are accelerating, but insight cycles don't always keep pace. This IQVIA white paper explores how synthetic advisory boards (S-ABs) use AI-enabled digital twins, under human oversight, to pressure-test scenarios before live advisory boards. Read now: https://lnkd.in/eef3nSFe
-
Did you know IQVIA holds the largest healthcare data library in the world? Get a glimpse behind the scenes into how we use data, analytics and collaboration to create more moments that matter for patients everywhere. Find your fit with us: https://bit.ly/4nKDevE #WeAreIQVIA
-
Join our webinar on May 28 to learn how external comparator (EC) studies can strengthen insights from pre‑pivotal single‑arm trials by providing context to assess compound performance and guide smarter prioritization and investment decisions. By using real‑world data, EC approaches can complement traditional early-stage trials and can help accelerate development. https://bit.ly/4v6X5HY
-
-
How do we ensure rigorous science translates into real-world patient impact when AI is transforming all stages of this journey? This week, IQVIA and Wiley convened 25 leading voices from pharma, academia, AI, and medical publishing for The Summit—a meeting that aligned the full AI-impacted scientific value chain around maintaining rigor and trust as AI accelerates scientific discovery. Stay tuned for the upcoming summary report.
-
-
Clinical trials are evolving to prove not just efficacy but true differentiation. As immunology becomes more complex, comparative evidence is essential to guide payer, HCP decisions and unlock value. Read our blog to discover more: https://bit.ly/42uPPJD
-